Sasha Girouard is a Dermatology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 11 publications with 404 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
134 Ansel Hallet Rd
W Yarmouth, MA 026732582
Telephone
508-771-9779Registry record last updated 20 Mar 2017.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- ABBVIE INC.Program year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
26.9%Corticosteroid11.8%Triamcinolone Acetonide67%Fluocinolone Acetonide18%Triamcinolone acetonide16%Part D + Part B≥81 patientsPolyene Antifungal4.6%Nystatin77%Nyamyc23%Part D<11 patients+ 5 more classes in this area
Anti-infectives
23.7%Azole Antifungal11.2%Ketoconazole100%Part D≥89 patientsNitroimidazole Antimicrobial4%Metronidazole100%Part D≥35 patients+ 4 more classes in this area
Sensory organs
18%Corticosteroid18%Clobetasol Propionate35%Betamethasone Diprop Augmented33%Hydrocortisone18%Betamethasone Dipropionate14%Part D≥49 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse
BMJ Supportive & Palliative Care
2014 - The Multidrug-Resistance Transporter ABCB5 is Expressed in Human Placenta
International Journal of Gynecological Pathology
2013 - Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: A case report and review of the literature
Dermatology Online Journal
2012 - Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature
Journal of Cutaneous Pathology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”